| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |